Therefore, hepatic arterial chemoembolization combined with radiofrequency ablation has obvious effect on liver function and immune function in patients with liver cancer, which may be related to the regulation of abnormally expressed HIF1α and VEGF levels in vivo. Here, HIF1A is linked to liver cancer.